FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to the use of a compound of general formula (I), a pharmaceutically acceptable salt, solvate, stereoisomer or tautomer thereof, for production of medicinal agent for treatment and prevention of hepatic fibrosis and related diseases, where the related disease is selected from the group consisting of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
EFFECT: treatment and prevention of liver fibrosis, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
7 cl, 7 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS OF THIENYL[3, 2-d]PYRIMIDINE-4-ON, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2012 |
|
RU2624021C2 |
| FLUORO-SUBSTITUTED CYCLIC AMINO COMPOUNDS AND METHODS FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2013 |
|
RU2605931C2 |
| COMBINATIONS WHICH INCLUDE RECEPTOR S1P AGONIST AND JAK3 KINASE INHIBITOR | 2005 |
|
RU2415678C2 |
| PET BOTTLES WITH A SINGLE-LAYER BARRIER TO CARBON DIOXIDE | 2012 |
|
RU2579595C2 |
| NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | 2017 |
|
RU2772283C2 |
| CYCLIC INDOLE-3-CARBOXAMIDE, PRODUCTION AND USE THEREOF AS THERAPEUTIC PREPARATIONS | 2009 |
|
RU2485102C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2701156C2 |
| CATALYTIC COMPONENT FOR POLYMERISING OLEFINS AND CATALYST, CONTAINING SUCH COMPONENT | 2005 |
|
RU2358987C2 |
| 5-AROMATIC ALKYNYL-SUBSTITUTED BENZAMIDE COMPOUND AND METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2016 |
|
RU2695371C2 |
| AGENT FOR PROTECTION OF CULTURED PLANTS FROM PHYTOTOXIC ADVERSE EFFECT OF HERBICIDES, N- ACYLSULFONAMIDES | 1997 |
|
RU2182423C2 |
